Last reviewed · How we verify
0.2% Chlorhexidine
At a glance
| Generic name | 0.2% Chlorhexidine |
|---|---|
| Also known as | OraldinePerio, Chlorhexidine 0.2%, Oraldine Perio |
| Sponsor | University of Santiago de Compostela |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Immediate Restoration of a New Implant With High Primary Stability (NA)
- PMPR and Chlorhexidine on Periodontal Disease and Vascular Function (NA)
- To Compare Post-Extraction Use of a Novel Ethylenediaminetetraacetic Acid (EDTA) Post-operative Mouth Rinse and Daily Use EDTA Mouth Rinse and Standard 0.12% Chlorhexidine (CHX) Post-operative Mouth Rinse and Daily Use Essential Oil (EO) Mouth Rinse. (NA)
- Antimicrobial Effect of Tropolone Containing Versus Tropolone Free Mouthwash (EARLY_PHASE1)
- Effectiveness of Chlorhexidine Impregnated Gauze Versus Povidone Iodine Dressing in Post Trauma Wound Care (NA)
- Assessment of Topical Application of Chitosan 0.2% Chlorhexidine Gel on Wound Healing in Diabetic Patients (NA)
- Comparative Evaluation of Guava Leaf Extract and Chlorhexidine Mouthwash in Patients With Chronic Gingivitis (NA)
- The Efficacy of Adjuvant Oral Care in Prevention of Ventilator Associated Pneumonia. (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- 0.2% Chlorhexidine CI brief — competitive landscape report
- 0.2% Chlorhexidine updates RSS · CI watch RSS
- University of Santiago de Compostela portfolio CI